131 results on '"Inoue, Daichi"'
Search Results
2. Minor introns impact on hematopoietic malignancies
3. HapReel: A Racket-shaped Haptic Display Controller for Presenting Vibrotactile and Force Feedback through Fingertip Deformation
4. Systematic evaluation of AML-associated antigens identifies anti-U5 SNRNP200 therapeutic antibodies for the treatment of acute myeloid leukemia
5. Two-year cumulative live-birth rates and maximum number of transfer cycles in women aged >40 years
6. Galvanic corrosion behavior of hot-dip Al and 55Al–Zn coatings applied to steel bolted joints in atmospheric environments
7. A Study of Soot Formation Process in a Jet-jet Interaction Region of Diesel Spray Flames with LII/LS Measurement
8. SETBP1 is dispensable for normal and malignant hematopoiesis
9. Extracellular vesicle-mediated remodeling of the bone marrow microenvironment in myeloid malignancies
10. Data from Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation
11. Data from Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation
12. Supplementary Figure from Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation
13. Supplementary Figure from Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation
14. Table S5 from Altered Nuclear Export Signal Recognition as a Driver of Oncogenesis
15. Table S6 from Altered Nuclear Export Signal Recognition as a Driver of Oncogenesis
16. Table S1 from Altered Nuclear Export Signal Recognition as a Driver of Oncogenesis
17. Data from Altered Nuclear Export Signal Recognition as a Driver of Oncogenesis
18. Table S3 from Altered Nuclear Export Signal Recognition as a Driver of Oncogenesis
19. Table S4 from Altered Nuclear Export Signal Recognition as a Driver of Oncogenesis
20. Supplementary Figures from Altered Nuclear Export Signal Recognition as a Driver of Oncogenesis
21. Table S2 from Altered Nuclear Export Signal Recognition as a Driver of Oncogenesis
22. Data from Altered Nuclear Export Signal Recognition as a Driver of Oncogenesis
23. Table S4 from Altered Nuclear Export Signal Recognition as a Driver of Oncogenesis
24. Table S5 from Altered Nuclear Export Signal Recognition as a Driver of Oncogenesis
25. Supplementary Methods from Altered Nuclear Export Signal Recognition as a Driver of Oncogenesis
26. Table S1 from Altered Nuclear Export Signal Recognition as a Driver of Oncogenesis
27. Supplementary Methods from Altered Nuclear Export Signal Recognition as a Driver of Oncogenesis
28. Supplementary Figures from Altered Nuclear Export Signal Recognition as a Driver of Oncogenesis
29. Supplementary Table Captions from Altered Nuclear Export Signal Recognition as a Driver of Oncogenesis
30. Table S3 from Altered Nuclear Export Signal Recognition as a Driver of Oncogenesis
31. Table S6 from Altered Nuclear Export Signal Recognition as a Driver of Oncogenesis
32. Table S2 from Altered Nuclear Export Signal Recognition as a Driver of Oncogenesis
33. Supplementary Table Captions from Altered Nuclear Export Signal Recognition as a Driver of Oncogenesis
34. An Application of Hybrid Meta-heuristics to Consensus-based Distributed Scheduling
35. Risk factors for empty follicle syndrome in assisted reproductive technology with gonadotropin‐releasing hormone agonist trigger
36. Systematic Evaluation of AML-Associated Antigens Identifies Novel Anti-U5 snRNP200 Therapeutic Antibodies for the Treatment of AML
37. Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation
38. Exploring the mechanistic link between SF3B1 mutation and ring sideroblast formation in myelodysplastic syndrome
39. Aberrant EVI1 splicing contributes to EVI1-rearranged leukemia
40. Dysregulated minor intron splicing in cancer
41. Predicting CTR of Regional Flyer Images Using CNN
42. MDS cells impair osteolineage differentiation of MSCs via extracellular vesicles to suppress normal hematopoiesis
43. LIGAND-ASSISTED LOW-TEMPERATURE GROWTH OF SnO2 NANOAGGREGATES
44. Impaired RAS Proteolysis Drives Clonal Hematopoietic Transformation
45. Targeting low-risk myelodysplastic syndrome with novel therapeutic strategies
46. ASXL1 mutations are associated with distinct epigenomic alterations that lead to sensitivity to venetoclax and azacytidine
47. Minor intron retention drives clonal hematopoietic disorders and diverse cancer predisposition
48. Mutant ASXL1 induces age-related expansion of phenotypic hematopoietic stem cells through activation of Akt/mTOR pathway
49. Bacillus cereus Sepsis in the Treatment of Acute Myeloid Leukemia
50. Successful outcome of a pregnancy derived from premature ovulation in a gonadotropin‐releasing hormone antagonist protocol: A case report
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.